Gemma Nixon

[Naisbitt Hypersensitivity Group @ImmunoPharm]

We have a fully-funded @DiMeN_DTP iCASE PhD Studentship available, working with @xl_meng as primary supervisor, @Gemnix and industry partner @ApconiXLtd to improve chemical and immunological assessment to drive safer development of PROTACS https://t.co/CyebBE7xRc

[University of Liverpool News @livuninews]

Scientists from @livuni have made a promising discovery in the fight against breast cancer. Researchers have created a biomedical compound that has the potential to stop its spread.

Find out more here➡️https://t.co/cYtdyBoWwE

[Academy of Medical Sciences @acmedsci]

We are asking researchers from across academia and industry to view, use and submit projects to our new #openaccess database mapping preclinical #covid19 drug discovery https://t.co/kXUcLtDKPZ

[Academy of Medical Sciences @acmedsci]

Our rapid response group is mapping ongoing & emerging #Covid_19 pre-clinical drug development to identify opportunities for collaboration, avoid duplication of effort and help prioritise the most promising research.
👉 https://t.co/g7X2unHY9B

#coronavirusuk #coronavirus

[Gemma Nixon @Gemnix]

Check out "3rd Romark Medicinal Chemistry Symposium Featuring the BMCS Lectureship" https://t.co/pFioM3voMh @Eventbrite @LivUni @livuniphyssci #medicinalchemistry #chemistry #drugdiscovery

[Gemma Nixon @Gemnix]

@RNA_julie And me to be in yours!

[Gemma Nixon @Gemnix]

A fantastic three days and a perfect way to spend #InternationalWomensDay2019. Very much looking forward to the rest of #SUSTAIN3 and beyond.

[AMS Careers @AMS_Careers]

Excited to welcome so many senior leaders to our Inspiring Women evening tonight - here’s a pic of the #SUSTAIN3 cohort! #InternationalWomensDay2019

[AMS Careers @AMS_Careers]

Today is the first day of the #SUSTAIN3 Residential workshop: the beginning of a year-long journey of tailored career development for women in STEM #WomeninLeadership #WomenInSTEM #InternationalWomensDay2019

[AMS Careers @AMS_Careers]

We're proud to welcome Dr Gemma Nixon @Gemnix to #SUSTAIN3 which launches 6 March. She's a @The_MRC funded researcher at @APTlivuni @livuniphyssci studying medicinal chemistry, drug discovery and target identification. Outside of research, she enjoys fitness & DIY/interior design